Publicaciones (154) Publicaciones de Pablo Pelegrin Vivancos

2024

  1. Cell-specific Extracellular Vesicles and Their miRNA Cargo Released Into the Organ Preservation Solution During Cold Ischemia Storage as Biomarkers for Liver Transplant Outcomes

    Transplantation

  2. Detection of inflammasome activation in liver tissue during the donation process as potential biomarker for liver transplantation

    Cell Death Discovery, Vol. 10, Núm. 1

  3. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

    Nature Communications, Vol. 15, Núm. 1

2023

  1. ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux

    The Journal of cell biology, Vol. 222, Núm. 8

  2. Colostrum Features of Active and Recovered COVID-19 Patients Revealed Using Next-Generation Proteomics Technique, SWATH-MS

    Children, Vol. 10, Núm. 8

  3. Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 5, pp. e168-e169

  4. Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation

    eBioMedicine, Vol. 87

  5. Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant

    Australasian Journal of Dermatology, Vol. 64, Núm. 2, pp. 260-267

  6. Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation

    Biomedicine and Pharmacotherapy, Vol. 167

  7. Evolution of the gasdermin family and pyroptosis

    Developmental and Comparative Immunology, Vol. 149

  8. Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 10, Núm. 3

  9. Measuring IL-1β Processing by Bioluminescence Sensors: Using a Bioluminescence Resonance Energy Transfer Biosensor

    Methods in Molecular Biology (Humana Press Inc.), pp. 47-53

  10. Measuring NLR Oligomerization III: Detection of NLRP3 and NLRC4 Complex by Bioluminescence Resonance Energy Transfer

    Methods in molecular biology (Clifton, N.J.), Vol. 2696, pp. 93-103

  11. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

  12. P2X7 receptor activation impairs antitumour activity of natural killer cells

    British Journal of Pharmacology, Vol. 180, Núm. 1, pp. 111-128

  13. Polyphenols as NLRP3 inflammasome modulators in cardiometabolic diseases: a review of in vivo studies

    Food and Function, Vol. 14, Núm. 21, pp. 9534-9553

  14. Preface

    Methods in Molecular Biology

  15. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients

    Frontiers in Immunology, Vol. 14

  16. The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis

    eBioMedicine, Vol. 97

2022

  1. ASC nanobodies to counteract the consequences of inflammasome activation

    EMBO Molecular Medicine, Vol. 14, Núm. 6